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Background
In Europe, the proportion of older adults aged 65 years and 
over is expected to grow from 32% in 2020 to 52% in 2050.1,2 
This will lead to a high demand for long term care services, 
since ageing is strongly associated with multimorbidity, limita-
tions in daily activities, and higher dependency in general.3,4 It 
is unlikely that this projected increase in the demand for inten-
sive long term care by older adults in a health care system in its 
current form will remain affordable. The main cost drivers of 
care for older adults currently are long term institutional care 
and hospitalization.5 Therefore, decision makers seek ways to 
restrain the rising expenditures on long-term care by substitut-
ing institutionalized care with home-based care, since the costs 
of home care are generally assumed to be lower than costs of 
institutionalized care.6 As a consequence, diverse EU policies 
promote home care for older adults.3,7 Home care is also pre-
ferred by most older adults themselves, as they value their 
independence.8
Most European countries now offer a wide range of home 
care services for older adults, including home nursing care, per-
sonal care, social care, and specific treatments (eg, physical 
therapy).9-11 However, the availability of home care, and the 
way in which home care is provided varies within and between 
counties.5,12 Care models are a useful multidimensional con-
cept to define the way care is delivered, also referred to as ‘a 
descriptive picture of practice which adequately represents the 
real thing’.13 Care models can distinguish between care prac-
tices with regard to, for example, the provision of social care 
services and the level of working arrangements in- and outside 
the organization.10 Other home care models described in the 
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literature focus on case management, integrated care, con-
sumer-directed care, or restorative care.14-16
Care delivery arranged according to different home care 
models may lead to differences in resource utilization and costs 
of care. Reviews reported that coordinated care, integrated care, 
case management, and consumer-directed care were found to 
delay nursing home admissions and decrease hospital use, but 
increased home-based service use.14,15,17,18 The results on costs, 
however, were inconclusive.14,15,17-20 When studying costs of 
care delivery, only a few of the included studies considered 
societal costs (costs of health, social and informal care). 
Especially in home care for older adults, this perspective is 
important, because it provides a comprehensive view of costs, 
while also showing shifts in the distribution of cost across cost 
categories. Insight into these shifts is necessary due to the 
increased relevance and provision of informal care and welfare 
support in the care of older adults with chronic disorders.
Understanding whether and how the organization of home 
care is related to societal costs may help policymakers and 
organizations to achieve costs reductions. To the best of our 
knowledge, no head-to-head comparisons of different home 
care models on societal costs have been performed previously. 
Therefore, the aim of this study was to benchmark societal 
costs (healthcare, home care and informal care costs) per client 
in different home care models and to describe characteristics of 
home care models with the lowest societal costs.
Methods
Design
This study has a prospective longitudinal design, with assess-
ments at baseline, 6 and 12 months. The study is part of the 
cross-European ‘Identifying best practices for care-dependent 
elderly by Benchmarking Costs and outcomes of community 
care’ (IBenC) project, funded within the 7th Framework 
Program of the European Commission. IBenCs primary aim is 
to identify best practices in home care models across Europe by 
comparing their costs and quality of care outcomes.21 The 
study was approved by relevant legally authorized medical ethi-
cal committees in the countries that participated in the IBenC 
project.
Setting and participants
Thirty-eight home care organizations from 6 countries, 
Belgium, Finland, Germany, Iceland, Italy, and the Netherlands, 
participated in the IBenC project. The IBenC sample con-
sisted of community-dwelling adults aged 65 years and older 
receiving home care from a (primary care) nurse, and expected 
to remain in care for at least 6 months after inclusion.
Procedure
Professional care organizations that offer health or social care 
to people in the community were invited by the national study 
centers to participate in the study. Participation of organiza-
tions already using the interRAI-HC in their care practice was 
preferred. Diversity between community care organizations 
regarding structures, size, and type of region (urban, rural, or 
mixed) was sought. After enrolment of care organizations, eli-
gible clients were selected from the organizations’ caseload. For 
participants from some organizations in The Netherlands and 
Italy that used the interRAI-HC in routine care practice, 
informed consent for the study was not required according to 
local regulations. All other clients signed an informed consent 
form before entering the study.
Information on client characteristics, health outcomes, and 
care utilization was collected at baseline, and after 6 and 
12 months between 2013 and 2016. The assessments were con-
ducted in the homes of the care recipients by trained (research) 
nurses. The questionnaire on organizational characteristics was 
completed by a key person of each of the participating care 
organizations.
Home care models
Six different home care models were distinguished based on 
information on organizational characteristics collected within 
the project. By means of a cross-sectional questionnaire that 
was designed specifically for use in the IBenC study,22 infor-
mation was collected on structural features, management, care 
processes, staff characteristics, and reimbursement systems. 
From these data, 3 core elements of care practice arrangements 
emerged: the level of patient-centred care, the availability of 
specialized care professionals, and the level of monitoring of 
care performance.22 Patient-centred care was operationalized 
using 6 items referring to elements of patient-centered care 
delivery such as actively involving clients and informal caregiv-
ers in care planning, or the availability of a client’s (digital) 
file.22,23 The availability of specialized care professionals was 
assessed using 5 items on employment of care professionals in 
specialized care domains, such as dementia care or palliative 
care. The third element, level of monitoring of care perfor-
mance, refers to the standardized assessment of quality of care 
and client satisfaction on received care and was operationalized 
by 4 items. Organizations were classified into 6 distinct home 
care models according to the level to which their care arrange-
ment met each of the core elements.22 Higher scores on an 
element indicate a higher focus on this core element of their 
care arrangement (see Figure 1). Care model 1 (CM1) is char-
acterized by a (very) strong focus on patient-centred care pro-
vided by specialized care professionals in which the performance 
of care is monitored closely. Care model 2 (CM2) is character-
ized by close monitoring of the performance of care that is very 
much patient-centered, but with little or no availability of spe-
cialized care professionals. Care model 3 (CM3) focuses on 
monitoring of care performance, with less focus on patient-
centered care and employment of specialized care profession-
als. Care model 4 (CM4) consists of patient-centered care that 

































Figure 1. Composition of the identified home care models according to core elements of care delivery.
Abbreviation: CM, care model.
Higher average scores indicate higher focus on the core element.
is provided by specialized care professionals, but monitoring of 
care performance is not routinely done. More details on the 
care models are included in the paper by Van Eenoo et al.22
Two of the 6 care models were excluded for this study (CM5 
and CM6), because only 2 organizations with a low number of 
respondents (n = 15 and n = 17) delivered care according to 
these models.
Measures
Client characteristics. To assess baseline client characteristics, 
the interRAI-Home Care (interRAI-HC) instrument was 
used. The interRAI-HC is a standardized and reliable compre-
hensive geriatric assessment instrument designed to assist in 
care planning, outcome measurement, quality improvement, 
and resource allocation for clients who receive care at home.24-
27 The instrument contains several validated outcome scales. 
Cognitive functioning is assessed by the Cognitive Perfor-
mance Scale (CPS, range 0-6). Moderate to severe cognitive 
impairment is considered to be present if the CPS score is 3 or 
higher.28 Depressive symptoms are assessed by the Depression 
Rating Scale (DRS, range 0-14). A score of 3 or higher on the 
DRS indicates the possible presence of minor or major depres-
sive disorder.29 Activities of daily living (ADL) needs were 
assessed with the interRAI Activities of Daily Living Hierar-
chy Scale (ADLH, range 0-6).30 Difficulties in performing 
instrumental activities (iADL) were assessed using the Instru-
mental ADL Performance Scale (iADLP, range 0-48).31 Med-
ical complexity/health instability was assessed using the 
Changes in Health, End-Stage Disease, Signs, and Symptoms 
Scale (CHESS, range 0-5).32,33 Higher scores on the above-
mentioned scales reflect higher complexity and care needs.
Care utilization. Health and social care utilization and infor-
mal caregiver time were assessed with the resource utilization 
items from the interRAI-HC at baseline and 6-month follow-
up. The interRAI-HC was considered a valid instrument to 
assess the use of care services from a societal perspective.34 The 
number of events or days and the total number of minutes of 
care received were registered. Recall periods were 90 days for 
hospitalization, emergency room and physician visits, 7 days for 
regular home care services and visits to therapists, and 3 days 
for informal care. Care utilization estimates (number of events, 
amount of time) were divided by their recall period in days, and 
multiplied by 91 days to reflect a period of 3 months. The inter-
RAI-HC assesses the number of hospital stays, but does not 
assess the number of nights (except for Belgium). To estimate 
the number of nights, we multiplied the reported number of 
events with country-specific averages of length of stay during 
hospital admission in the year 201235 (Appendix 1). In Bel-
gium, the registered total number of hospital admission days 
was used instead of OECD estimates.
Dependent variable. Societal costs of care utilization over a 
6-month period were calculated by multiplying resource utili-
zation with Dutch standard costs.36 Cost of informal care was 
estimated by multiplying informal care hours with the wage 
rate of a legally employed cleaner.36 Using uniform costs 
ensures that differences between care models are not influ-
enced by country specific price differences. For institutional-
ized or deceased respondents, we assumed that the event 
occurred halfway between the 2 assessments. Costs after 
admission to another care setting were calculated using stand-
ard cost per day for the specific facilities, and costs after death 
were determined to be zero.
Seven cost categories were distinguished (Appendix 1) and 
summed into total societal costs. To calculate the societal costs 
over a 6-month period, costs between assessments were linearly 
interpolated by multiplying costs at baseline assessment by 0.5, 
and costs at 6-month follow-up were multiplied by 1.5. Thus 
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costs in the first 3 months were based on the average of the costs 
at baseline assessment and 6-month follow up, while costs in 
the seconds 3 months were based on the 6-month assessment.
Analysis strategy
All analyses were performed using SPSS statistics 20 and 
STATA 12 SE. Baseline characteristics were described using 
descriptive statistics and frequencies. Differences in baseline 
characteristics between participants from different home care 
models, and between participants who dropped out and par-
ticipants who remained in the study were evaluated using Chi-
square tests for categorical variables and analysis of variance 
(ANOVA) tests for continuous variables. The significance level 
was set at 0.05 in all analyses.
Missing cost data at 6 months were imputed using multiple 
imputation with chained equations in SPSS.37 Predictive mean 
matching was used to account for the skewed distribution of 
costs. Baseline characteristics that were significantly associated 
with costs after 6 months, differed significantly between home 
care models, or between respondents with and without follow-
up were included in the imputation model. Ten datasets were 
created. Each imputed dataset was analyzed separately, and the 
results of the analyses were pooled using Rubin’s rules.38
The amount of informal caregiving time was not assessed in 
Belgium. Therefore, CM4 (Belgian organizations only) was not 
included in the main analysis from a societal perspective. Mean 
disaggregated costs and total societal costs were calculated per 
client over a 6-month period stratified for each care model. 
Differences in costs per client between home care models were 
analyzed using linear regression with dummy variables for the 
home care models. Because of the skewed distribution of cost 
data, 95% confidence intervals (CIs) were estimated using bias-
corrected accelerated bootstrapping with 5000 replications. 
Differences were adjusted for the following case mix variables: 
age, sex, living status, CPS, DRS, ADLH, IADL, and CHESS. 
Also country of residence was explored as potential confounder. 
Collinearity between covariates was investigated using 
Spearman rho correlation coefficients (cut-off value r > 0.4).
Two sensitivity analyses were performed. First, an analysis 
was performed from a healthcare perspective (excluding infor-
mal care costs) including Belgian participants (16 organiza-
tions, n = 493). Two Belgian organizations (n = 32) were 
excluded since they were assigned to the 2 care models that 
were not considered in this study (n too small). Second, to eval-
uate the robustness of the valuation method on the results, 
units of resource utilization were multiplied by Italian prices39-41 
indexed to the year 2015, which considerably deviated from the 
Dutch standard costs (Appendix 1).
Results
A total of 2060 participants in 3 care models from the original 
sample (n = 2884) were included in the main analyses. Data 
from 824 respondents were excluded from the main analysis; 
because of software problems data collection of interRAI-HC 
was put on hold in 1 Dutch organization (n = 224) and uncol-
lected information on informal care hours in Belgium (18 
organizations, n = 525). In addition, 2 German organizations 
could not be assigned to a care model due to incomplete data 
(n = 75). CM1 contained 6 organizations and 1331 participants 
(65%), CM2 respectively 3 and 311 (15%), and CM3 9 organi-
zations and 418 participants (20%). See Table 1.
In total, 29% of the participants had missing values on one 
or more resource utilization items. The amount of missingness 
was 0% for costs of institutionalized care, and 6% to 7% for the 
other cost categories.
Two-thirds of the participants in the study sample were 
female, and the mean age was 82.8 years (SD = 7.5) (P > .05). 
Participants in CM1 lived less often alone (49%), received the 
largest amount of informal care at baseline (30.4 hours per 
week, SD = 1.1), and the frequency of caregiver distress was 
higher as compared to the other CMs (P < .01). In CM2, par-
ticipants were least impaired in cognition, only 6% experienced 
moderate to severe cognitive impairment, and in (i)ADL 
(P < .01). CM3 contained participants with the highest impair-
ments in cognition (28% moderate to severe cognitive impair-
ment) and (i)ADL, and had the highest rate of depressive 
symptoms (20%) as compared to participants in the other CMs 
(P < .01). They also received the largest amount of professional 
home care per week at baseline compared to participants in the 
other CMs (6.8 hours, SD = 0.3) (P < .01). See Table 1.
Between the baseline and 6-month follow up assessments, 
3% (n = 91) of the participants were admitted to a nursing 
home, hospital, or rehabilitation facility, 2% (n = 71) died, <1% 
(n = 14) were discharged from home care, and 2% of the par-
ticipants were lost for follow-up due to lack of interest or time 
(n = 16) or without reason (n = 37). In CM3, 7% of the partici-
pants died, which was higher compared to the other CMs (1%-
3%) (P < .05). Compared to the completers, the drop-outs 
were statistically significantly older (P < 0.05).
With average costs per client of €16221 (SE = 854) over 
6 months, mean unadjusted total societal costs per client were 
lowest in CM2 and highest in CM1 (€18800, SE = 404) 
(Figure 2). In CM1, approximately 60% of the total societal 
costs was attributed to informal care, this share was much 
lower in CM3 (25%) and CM2 (35%). In CM3, home care 
accounted for approximately 54% of total societal costs, which 
was considerably higher compared to the other care models. 
CM3 generated relatively few hospitalization costs (6% of 
total share), while this share was almost double for CM1 and 
CM2. Costs of physician visits, other healthcare services, sup-
portive care services, and institutional care only contributed 
marginally to the total societal costs. See Appendix 2 and 3 for 
more details.
After adjusting for case mix, mean total societal costs per 
client in CM2 were statistically significantly higher than in 
CM1 (mean difference €2230, 95% CI 551; 4179) and in CM3 
(mean difference €2552, 95% CI 588; 4599) (Figure 3a). 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6 Health Services Insights 
Differences in mean total societal costs per client between 
CM1 and CM3 were not statistically significant (mean differ-
ence €321, 95% CI −1180; 1723). Country of residence did not 
explain any additional variance and was not included as a 
covariate.
Sensitivity analyses
A sensitivity analysis was performed from a healthcare perspec-
tive including Belgian participants (16 organizations, n = 493). 
Belgian participants received care that was mostly provided 
according to CM1 (n = 385, 78%) and CM4 (n = 87, 18%), with 
a smaller proportion receiving care according to CM3 (n = 21, 
4%). After including Belgian participants, a lower proportion of 
the participants in CM1 lived alone and relatively more experi-
enced depressive symptoms. Also, slightly higher rates were 
found for (i)ADL impairment and the amount of professional 
home care. Baseline characteristics of participants in CM3 
hardly differed. Participants in CM4 had more ADL limita-
tions (2.6, SD = 1.40) as compared to participants in the other 
CMs (P < .01) (See Figure 1 and Appendix 2).
Mean unadjusted total healthcare costs per client were low-
est in CM1 (€9333, SE = 221) and highest in CM3 (€13701, 
SE = 533). CM1 was associated with the lowest share (as pro-
portion of total healthcare costs) for home care (53%) and the 
highest share for hospital admissions (24%), as compared to 
the other CMs. In CM3, home care accounted for approxi-
mately 73% of total healthcare costs, which was considerably 
higher than in the other CMs. In CM4, 61% of total healthcare 
costs could be attributed to home care and 11% to 12% to hos-
pital admissions and supportive care.
After adjustment for case mix variables, as compared to the 
other care models, CM1 was associated with statistically sig-
nificantly lower healthcare costs per client than in CM2 (mean 
difference €−2297, 95% CI (−3510; −1242), CM3 (mean dif-
ference €−3405, 95% CI (−4484; −2385), and in CM4 (mean 
difference €−3644, 95% CI (−5898; −1826). CM4 was associ-
ated with the highest healthcare costs per client, but differences 
between this model and CM2 and CM3 were not statistically 
significant (Figure 3b).
In the second sensitivity analysis, 6-month societal costs 
were estimated using Italian prices. The results were compara-
ble, although cost differences across models were less pro-
nounced. CM2 was still associated with statistically significantly 
higher societal costs per client than CM1 (mean difference 
€779, 95% CI 98; 1581) and CM3 (mean difference €1072, 
95% CI 265; 1935). Total societal costs per client in CM3 were 
not significantly lower than those in CM1 (mean difference 
€−274, 95% CI −865; 338).
Discussion
To the best of our knowledge, this is the first study in which 
home care models in a large European sample were compared 
on the basis of societal and healthcare costs. We found that 2 
distinct home care models (CM1 and CM3) were associated 
with statistically significantly lower societal costs per client as 
compared to the third care model (CM2). Also, the ratio of 
home care costs to informal care costs differed considerably 
between these 2 care models. Of the 2 care models with the 
lowest societal costs, 1 model was characterized by a low focus 
on patient-centred care and employment of mainly generalist 
care professionals, which resulted in relatively high home care 
costs and low informal care costs (CM3, ratio 1:0.5). In con-
trast, the other had a strong focus on patient-centered care in 
combination with high availability of specialized care profes-
sionals, and relatively low home care costs and high informal 
care costs (CM1, ratio 1:3), implying that only a small part of 
day-to-day care is provided by professionals. Both models also 
focused on monitoring of care performance.
In light of the current reforms of long-term care to limit 
care expenses, the ratio of professional home care to informal 



































Societal perspective Healthcare perspective
Figure 2. Six-month cost of care estimates per client not adjusted for case mix differences across home care models.
Abbreviation: CM, care model.
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reforms aim at a reduction in the intensity of professional home 
care in combination with strengthening the involvement of 
informal caregivers. As a consequence, families are facing 
increased responsibilities for providing care in old age.42 It is 
questionable whether this situation is fully desirable as, for 
example, costs of hospital admissions were relatively high in 
CM1, as was caregiver distress. Research shows that caregiver 
distress is related to increased healthcare utilization and lost 
productivity in informal caregivers.43 In CM3 lower levels of 
caregiver distress were reported, even though the clients in this 
model had more severe impairments at baseline than those in 
CM1. So, possibly the amount of professional home care in 
CM1 is insufficient, resulting in adverse effects, such as hospi-
talization of clients and overburdening of informal caregivers. 
These results highlight the importance of early identification 
of persons ‘at-risk’ of hospitalization and caregiver distress in 
situations where relatively little professional home care is pro-
vided in relation to informal care.
CM2, which was associated with the highest societal costs, 
differs from the other care models by its low availability of spe-
cialized care professionals combined with a relatively strong 
focus on both patient-centered care and monitoring of care 
performance. The ratio of home care costs to informal care 
costs was 1:2. Interesting here is that the highest adjusted soci-
etal costs were generated by this model, while the dependency 
levels of the clients served through this model were relatively 
the lowest, implying that, on average, clients received more care 
regardless of their health status as compared to the other 
models. As such, the efficiency of the care provided in CM2 is 
suboptimal.
Considerations
An advantage of classifying the care as provided by care organi-
zations into care models to study efficiency, is that a variety of 
different organizational elements of home care organizations 
regarding structure, management, care processes, staff charac-
teristics, reimbursement systems are reduced to a number of 
relevant core domains that define the way care is delivered.12 
This makes it easier to study care practices and their costs, as 
this enabled us to group home care clients into our analyses. 
However, the number of respondents in 2 of 6 care models was 
too small to include in our analyses. Therefore, we may have 
missed relevant costs differences between care models due to 
power issues. Also, as the care models that were included in the 
main analysis only differed on 2 of the 3 core elements, it was 
difficult to draw concrete conclusions on the relation between 
the elements that formed the care models and societal costs.
International benchmarking, as was done in this study, is 
useful in trying to find innovative and alternative ways of pro-
viding (home) care services in responding to the problem of 
rising expenditures on long-term care.44 Especially when an 
organization is providing a unique service and there are no 
organizations within the country that to benchmark with, 
international benchmarking can bring important added value. 
Further, it may reveal more differences in performance than if 
-€ 2,000 € 0 € 2,000 € 4,000 € 6,000
CM1 versus CM3
CM2 versus CM3
a. Societal perspective 





Figure 3. Mean adjusted differences in total societal (a) and healthcare (b) costs per client between the care models.
Abbreviation: CM, care model.
In the comparisons, the care model with the lowest costs act as reference. 95% confidence intervals were estimated using bias-corrected and accelerated bootstrapping 
with 5000 replications. Significant differences in costs between a care model and the reference care model can be considered when the confidence interval do not cross 
the €0 costs line. Significant differences in costs between care models can be considered when their confidence intervals do not overlap.
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the comparison is only done within a country. Usually more 
divers practices will be found if organizations are compared 
across a number of countries. To increase diversity even more, 
we purposefully sampled diverse home care organizations and 
classified them into different care models. Although interna-
tional benchmarking has clear benefits, it is also a complicated 
type of benchmarking as there is a transfer-problem.45 A sim-
ple transfer of care models that are associated with low societal 
costs is complicated by different national structures and soci-
etal preferences.46 Also, we cannot be sure that results will be 
the same if other patient groups receive care according to the 
care models defined. Nevertheless, if it appears that a particular 
care model leads to better care against lower societal costs, care 
organizations should be encouraged to align their care with 
this care model, while closely monitoring their performance.12
In international costing studies, it is recommended to use 
country-specific standard unit costs to value health services as 
this approaches societal opportunity costs.47 The application of 
standard unit costs enables a meaningful comparison of costs 
differences that result from the different care practices.48,49 
This way cost differences can be attributed to differences in 
resource utilization, rather than to differences in costing meth-
odology.50,51 Standard unit costs were not available for all ser-
vices for all countries under study. Instead, we used Dutch 
standard costs in the main analysis and Italian standard costs in 
a sensitivity analysis. Consequently, we were able to provide a 
relative benchmark of societal costs and healthcare costs across 
care models. The disadvantage of using this approach, is that 
costs do not reflect actual care costs within the included 
countries.
Several approaches can be used to adjust for case-mix differ-
ences at baseline in observational studies. The most traditional 
approach to handle this is covariate adjustment using regres-
sion modelling. Commonly used alternatives include matching 
or balancing techniques to match similar individuals in the 
comparison groups with the aim to achieve a balance in covari-
ates across groups, for example by using propensity scores.52-54 
These alternative approaches have theoretical advantages over 
covariate adjustment. However, studies comparing the perfor-
mance of covariate adjustment with these alternative approaches 
did not show that these alternative approaches are necessarily 
superior to covariate adjustment.55-57 Since matching becomes 
more complicated when there are more different groups, we 
decided to use multivariate regression analysis to adjust for case 
mix differences.
Strengths and limitations
This study is the first to benchmark costs associated with dif-
ferent home care models. Another strength of this study is that 
a large number of organizations and clients from 6 European 
countries were included in the analyses, enabling comparison 
of costs between different care models. Care models were clas-
sified according to detailed information of participating home 
care organizations. The care model core elements together 
explained a substantial and sufficient proportion (75.4%) of the 
variance within organizational characteristics.22 Another 
strength is that the interRAI-HC assessments are reliable and 
valid sources of clinical functioning as well as of formal and 
informal resource use.24,34 Uniform data collection using a valid 
instrument greatly facilitated reliable cross-national societal 
cost comparisons at an organizational level, including case mix 
adjustment. Using routine care data for cost of care assessments 
keeps the burden for participants and care organizations low. 
Furthermore, differences in societal costs were robust for rela-
tively different nations’ prices/tariffs, since the initial conclu-
sions of the study did not change when resource utilization was 
valued with Italian standard costs.
Distinct differences between the care models that were 
included in the main analysis were limited, which can be a 
potential limitation of the study. We could not include 2 of the 
6 identified care models, because only 2 organizations with a 
low number of respondents delivered care according to these 
models. Further, client groups between care models differed 
considerably. We adjusted for case mix characteristics to 
account for this. Another limitation is that the exact length of 
hospital stays was not recorded in the interRAI-HC (except 
for Belgium) and was estimated using averages from the 
Organization for Economic Cooperation and Development 
(OECD), resulting in 2 different approaches that were used to 
value hospital stays.35 Finally, participants were lost to analysis 
due to software omissions, and informal caregiver time was not 
registered in Belgium. Most Belgian clients received care 
according to CM4, which was totally excluded in the main 
analysis, while a small percentage received care according to 
CM1 and CM3.
Conclusions
Results from international benchmarking of home care models 
on costs of resource utilization provide insights in the costs 
resulting from different home care practices. All 3 care models 
that were included in the main analysis had a strong focus on 
monitoring care performance. Two opposite models were asso-
ciated with the lowest societal costs. One was further charac-
terized by a low focus on patient-centered care and employment 
of mainly generalist care professionals, while the other had a 
strong focus on patient-centered care in combination with a 
high availability of specialized care professionals. Therefore, it 
was difficult to draw definite conclusions on the relation 
between the core elements of the care models and societal 
costs. Our results suggest that low societal costs can be achieved 
in different ways which can have more or less favorable out-
comes for clients or informal caregivers. Future benchmarking 
studies of home care models on societal costs should focus on 
the contribution of home care costs and informal care costs to 
societal costs, as the ratio of home care to informal care differed 
considerably between the models. Considering current reforms 
of long-term care in many European countries, the ratio of 
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home care to informal care in the model with a strong focus on 
patient-centered care in combination with a high availability of 
specialized care professionals seems more favorable than the 
one in the other model with lowest societal costs. Early identi-
fication of persons ‘at-risk’ of hospitalization and caregiver dis-
tress might be important focus areas for home care organizations 
that provide relatively little home care in relation to informal 
care.
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Appendix 1. Overview of cost categories with associated unit costs (in €2015) and average length of stay (days).
CARE SERVICE DUTCH COSTS36 ITALIAN COSTS39-41*
Home care
 Home health aide (per hour) €50 €18
 Home nursing (per hour) €73 €24
Physician visits
 General practitioner visit/outpatient clinic visit (per visit) €92 €57
Other healthcare services
 Physical therapy (per session) €33 €26
 Occupational therapy (per session) €34 €26
 Social worker (per session) €64 €22
Hospital admissions
 Hospital admission with overnight stay (per day with overnight stay) €479 €405
 Average length of hospital stay35 Days  
 Finland 11.0  
 Germany 9.2  
 Iceland 5.8  
 Italy 7.7  
 Netherlands 5.2  
 Emergency room visit without overnight stay (per visit) €261 €242
Supportive care services
 Home making services (per hour) €23 €18
 Meals on wheels (per day) €7.50 €6.8**
Institutionalized care
 Nursing home (per day) €168 €152**
 Rehabilitation institute (per day) €460 €417**
Informal care
 Informal care (per hour) €14.08 €3.75
*Italian prices were used for sensitivity analysis.
**Not available, Dutch standard costs were converted into Italian prices using Purchasing Power Parities (PPP).
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